Monoamine Oxidase Inhibitors (MAOIs)

Psychiatric

Mark this drug class

Examples

phenelzinetranylcypromineselegilineisocarboxazid

Prefix / Suffix: No consistent suffix

Physiology

Monoamine oxidase breaks down serotonin, norepinephrine, and dopamine. Inhibiting it increases their levels.

Mechanism of Action

Inhibit monoamine oxidase enzymes, preventing breakdown of monoamine neurotransmitters.

Indications

  • Treatment-resistant depression
  • Atypical depression
  • Parkinson's disease (selegiline)

Side Effects / Adverse Effects

  • Hypertensive crisis with tyramine-containing foods
  • Orthostatic hypotension
  • Insomnia
  • Weight gain
  • Serotonin syndrome with serotonergic drugs

Contraindications

  • Concurrent SSRIs, SNRIs, TCAs (wait 2 weeks; 5 weeks for fluoxetine)
  • Pheochromocytoma
  • Severe cardiovascular disease
  • Foods high in tyramine

Nursing Considerations

  • Strict tyramine-free diet β€” avoid aged cheeses, cured meats, fermented foods, soy sauce, tap beer, red wine (hypertensive crisis)
  • Teach signs of hypertensive crisis: severe headache, neck stiffness, chest pain, palpitations
  • Avoid OTC cold medicines, decongestants (sympathomimetics)
  • Wait 2 weeks before/after switching antidepressants (5 weeks for fluoxetine)
  • Monitor BP regularly
  • Used as last-line due to dietary restrictions and interactions

Ask PharmPal Nurse

Your AI tutor for Monoamine Oxidase Inhibitors (MAOIs)

Ask me anything about this drug class.

Disclaimer: PharmPal Nurse is for education only and is not medical advice. Do not use it to diagnose, treat, prescribe, or make patient-care decisions; always verify with current drug references, your instructor, facility policy, and a licensed provider. In emergencies, call local emergency services.